User profiles for Naoki Nishio
Naoki NishioNagoya University, Stanford University Verified email at med.nagoya-u.ac.jp Cited by 1822 |
Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer
N Nishio, NS van den Berg, S van Keulen… - Nature …, 2019 - nature.com
Identification of lymph node (LN) metastasis is essential for staging of solid tumors, and as a
result, surgeons focus on harvesting significant numbers of LNs during ablative procedures …
result, surgeons focus on harvesting significant numbers of LNs during ablative procedures …
Endolymphatic hydrops revealed by intravenous gadolinium injection in patients with Meniere's disease
…, M Sone, H Otake, K Kato, T Iwata, N Nishio - Acta oto …, 2010 - Taylor & Francis
Conclusion: Visualization of endolymphatic hydrops became possible after intravenous
gadolinium (Gd) injection in patients with Ménière's disease. Objective: To visualize …
gadolinium (Gd) injection in patients with Ménière's disease. Objective: To visualize …
The clinical application of fluorescence-guided surgery in head and neck cancer
S van Keulen, N Nishio, S Fakurnejad… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Although surgical resection has been the primary treatment modality of solid tumors for
decades, surgeons still rely on visual cues and palpation to delineate healthy from cancerous …
decades, surgeons still rely on visual cues and palpation to delineate healthy from cancerous …
Optimal dosing strategy for fluorescence-guided surgery with panitumumab-IRDye800CW in head and neck cancer
N Nishio, NS van den Berg, S van Keulen… - Molecular imaging and …, 2020 - Springer
Purpose To identify the optimal dosing strategy for fluorescence-guided surgery in patients
with head and neck squamous cell carcinoma, we conducted a dose-ranging study …
with head and neck squamous cell carcinoma, we conducted a dose-ranging study …
Co-administered antibody improves penetration of antibody–dye conjugate into human cancers with implications for antibody–drug conjugates
Poor tissue penetration remains a major challenge for antibody-based therapeutics of solid
tumors, but proper dosing can improve the tissue penetration and thus therapeutic efficacy of …
tumors, but proper dosing can improve the tissue penetration and thus therapeutic efficacy of …
Photoacoustic molecular imaging for the identification of lymph node metastasis in head and neck cancer using an anti-EGFR antibody–dye conjugate
N Nishio, NS van den Berg, BA Martin… - Journal of Nuclear …, 2021 - Soc Nuclear Med
The presence of lymph node (LN) metastases is an essential prognostic indicator in patients
with head and neck squamous cell carcinoma (HNSCC). This study assessed …
with head and neck squamous cell carcinoma (HNSCC). This study assessed …
The Sentinel Margin: Intraoperative Ex Vivo Specimen Mapping Using Relative Fluorescence Intensity
Purpose: Despite major advancements in surgical oncology, the positive margin rate for
primary head and neck cancer resection remains around 15%–30%. In particular, the deep …
primary head and neck cancer resection remains around 15%–30%. In particular, the deep …
Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma
Objective Surgical resection remains the primary treatment for the majority of solid tumors.
Despite efforts to obtain wide margins, close or positive surgical margins (<5 mm) are found in …
Despite efforts to obtain wide margins, close or positive surgical margins (<5 mm) are found in …
Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose …
Background Complete surgical resection remains the primary curative option for pancreatic
ductal adenocarcinoma, with positive margins in 30–70% of patients. In this study, we aimed …
ductal adenocarcinoma, with positive margins in 30–70% of patients. In this study, we aimed …
[HTML][HTML] EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial
Rationale: First-line therapy for high-grade gliomas (HGGs) includes maximal safe surgical
resection. The extent of resection predicts overall survival, but current neuroimaging …
resection. The extent of resection predicts overall survival, but current neuroimaging …